Researchers are exploring the therapeutic potential of targeting myeloid cells, including macrophages, in the treatment of liver fibrosis. The mechanisms and clinical prospects of this approach are being investigated, with potential applications also being considered for other diseases, such as cancer and pulmonary fibrosis. Studies are examining the roles of various cell types and biological processes, including immunological mechanisms and metabolic pathways, in these diseases.